Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oestrogen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01120665
What this trial is testing

Isolated and Associated Effects of Physical Exercise and Estrogen Therapy on Climactercs Women

Who this might be right for
Women's Health
University of Sao Paulo General Hospital 62
Not applicableLooking for participantsNCT07686718
What this trial is testing

To Establish Whether Individuals With Premenstrual Dysphoric Disorder (PMDD) Demonstrate a Different Luteal-phase Sex Hormone Profile and Ratio Compared With Asymptomatic Controls.

Who this might be right for
Premenstrual Dysphoric Disorder ( PMDD)
Lancaster University 50
Not applicableStudy completedNCT01023178
What this trial is testing

Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure

Who this might be right for
Ovarian Failure, Premature
Stanford University 20
Large-scale testing (Phase 3)Looking for participantsNCT06969326
What this trial is testing

Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy

Who this might be right for
Postoperative BleedingGender DysphoriaHysterectomy
Women and Infants Hospital of Rhode Island 48
Early research (Phase 1)Study completedNCT02219789
What this trial is testing

Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery

Who this might be right for
Estrogen Receptor PositiveProgesterone Receptor PositiveRecurrent Breast Carcinoma+3 more
Mayo Clinic 10
Testing effectiveness (Phase 2)Study completedNCT04294225
What this trial is testing

Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+19 more
Mayo Clinic 161
Not applicableLooking for participantsNCT07053982
What this trial is testing

Use of a New Diagnostic Tool in the Detection and Characterization of Endometriosis Lesions

Who this might be right for
Endometriosis
University Hospital, Toulouse 20
Testing effectiveness (Phase 2)Study completedNCT01089049
What this trial is testing

Effect of a Natural Health Product on Urinary Estrogen Metabolites

Who this might be right for
Breast Cancer
Nutrasource Pharmaceutical and Nutraceutical Services, Inc. 98
Testing effectiveness (Phase 2)Ended earlyNCT01151449
What this trial is testing

Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerHER2-negative Breast CancerMale Breast Cancer+7 more
National Cancer Institute (NCI) 6
Early research (Phase 1)Active Not RecruitingNCT04052555
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer

Who this might be right for
Bilateral Breast CarcinomaHER2-Negative Breast CarcinomaLocalized Breast Carcinoma+2 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07275463
What this trial is testing

[99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression

Who this might be right for
Primary Breast Cancer
Tomsk National Research Medical Center of the Russian Academy of Sciences 40
Not applicableStudy completedNCT02625935
What this trial is testing

Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients

Who this might be right for
Breast Cancer
NanoString Technologies, Inc. 206
Testing effectiveness (Phase 2)Active Not RecruitingNCT02734290
What this trial is testing

Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Providence Health & Services 29
Early research (Phase 1)UnknownNCT05118685
What this trial is testing

Estrogen and Platelet Rich Plasma in Treatment of Atrophic Vaginitis

Who this might be right for
Atrophic VaginitisPostmenopausal Atrophic Vaginitis
Fayoum University 100
Large-scale testing (Phase 3)Study completedNCT02422615
What this trial is testing

Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.

Who this might be right for
Advanced Breast Cancer
Novartis Pharmaceuticals 726
Not applicableLooking for participantsNCT06683248
What this trial is testing

The Effects of Night Shift Work on Health Across the Menstrual Cycle

Who this might be right for
Sleep DeprivationMenstrual CycleBrain Health+3 more
Uppsala University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02311933
What this trial is testing

Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer

Who this might be right for
Recurrent Breast CarcinomaStage III Breast Cancer AJCC v7Stage IIIA Breast Cancer AJCC v7+3 more
National Cancer Institute (NCI) 81
Large-scale testing (Phase 3)Study completedNCT00044291
What this trial is testing

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasms, Hormone-dependent
Intarcia Therapeutics 865
Testing effectiveness (Phase 2)Study completedNCT01605396
What this trial is testing

A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064)

Who this might be right for
Breast Neoplasms
Merck Sharp & Dohme LLC 80
Not applicableUnknownNCT01004796
What this trial is testing

Study of Biomarkers in Tissue Samples From Patients With Breast Cancer

Who this might be right for
Breast Cancer
University of Wisconsin, Madison
Next Page